Analyst Price Targets — SGHT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 2, 2026 1:19 pm | — | Cantor Fitzgerald | $8.00 | $5.44 | StreetInsider | Sight Sciences Inc. (SGHT) PT Raised to $8 at Stifel Following Optometrist Survey |
| January 5, 2026 10:56 am | Matt O'Brien | Piper Sandler | $9.00 | $7.48 | TheFly | Sight Sciences upgraded to Overweight from Neutral at Piper Sandler |
| January 5, 2026 8:54 am | — | Raymond James | $9.00 | $7.48 | StreetInsider | Piper Sandler Upgrades Sight Sciences Inc. (SGHT) to Overweight |
| December 23, 2025 12:54 am | — | UBS | $12.00 | $8.44 | TheFly | Sight Sciences price target raised to $12 from $7 at UBS |
| December 10, 2025 1:58 pm | — | Lake Street | $12.00 | $8.47 | TheFly | Sight Sciences price target raised to $12 from $7 at Lake Street |
| December 2, 2025 11:38 am | Patrick Wood | Morgan Stanley | $8.00 | $8.17 | TheFly | Sight Sciences price target raised to $8 from $6 at Morgan Stanley |
| October 21, 2025 12:43 pm | — | Lake Street | $7.00 | $4.57 | TheFly | Sight Sciences price target raised to $7 from $5 at Lake Street |
| June 18, 2025 10:50 am | Matt O'Brien | Piper Sandler | $4.00 | $4.27 | TheFly | Sight Sciences price target raised to $4 from $3.50 at Piper Sandler |
| March 6, 2025 12:00 pm | — | Stifel Nicolaus | $4.00 | $2.49 | TheFly | Sight Sciences price target lowered to $4 from $5 at Stifel |
| November 4, 2024 1:08 pm | Frank Takkinen | Loop Capital Markets | $5.00 | $4.66 | StreetInsider | Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold |
Latest News for SGHT
Sight Sciences, Inc. (SGHT) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Sight Sciences (SGHT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.28 per share a year ago.
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SGHT.
U.S. House Trading
No House trades found for SGHT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.